These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68 related articles for article (PubMed ID: 1641357)
1. [The detection of inflammation and the formation of HAMA following the administration of monoclonal antibody BW 250/183]. Berberich R; Hennes P; Alexander C Nuklearmedizin; 1992 Jun; 31(3):70-3. PubMed ID: 1641357 [TBL] [Abstract][Full Text] [Related]
3. Detection of soft-tissue infections and osteomyelitis using a technetium-99m-labeled anti-granulocyte monoclonal antibody fragment. Becker W; Bair J; Behr T; Repp R; Streckenbach H; Beck H; Gramatzki M; Winship MJ; Goldenberg DM; Wolf F J Nucl Med; 1994 Sep; 35(9):1436-43. PubMed ID: 8071688 [TBL] [Abstract][Full Text] [Related]
4. In vivo labelling of granulocytes with 99mTc anti-NCA monoclonal antibodies for imaging inflammation. Joseph K; Höffken H; Bosslet K; Schorlemmer HU Eur J Nucl Med; 1988; 14(7-8):367-73. PubMed ID: 3181186 [TBL] [Abstract][Full Text] [Related]
5. Immunoscintigraphy of inflammatory processes with a technetium-99m-labeled monoclonal antigranulocyte antibody (MAb BW 250/183). Lind P; Langsteger W; Költringer P; Dimai HP; Passl R; Eber O J Nucl Med; 1990 Apr; 31(4):417-23. PubMed ID: 2157831 [TBL] [Abstract][Full Text] [Related]
6. Granulocyte labelling kit BW 250/183--results of the European multicenter trial. Steinsträsser A; Oberhausen E Nuklearmedizin; 1996 Feb; 35(1):1-11. PubMed ID: 8746166 [TBL] [Abstract][Full Text] [Related]
7. [Kinetics and immunocytochemical staining of 99mTc-labeled monoclonal anti-CEA antibodies against granulocytes following intravenous administration]. Maschek W; Neumüller H; Pastl K; Höpfel I; Dienstl E; Böhler N; Syre G Nuklearmedizin; 1990 Feb; 29(1):19-23. PubMed ID: 1690879 [TBL] [Abstract][Full Text] [Related]
8. Immunoscintigraphy using a technetium-99m labelled monoclonal anti-CEA antibody in the follow-up of colorectal cancer and other tumours producing CEA. Hertel A; Baum RP; Lorenz M; Baew-Christow T; Encke A; Hör G Br J Cancer Suppl; 1990 Jul; 10():34-6. PubMed ID: 2166552 [TBL] [Abstract][Full Text] [Related]
9. [The clinical relevance of anti-CEA immunoscintigraphy with the 99mTc-labelled monoclonal antibody BW 431/26. A critical assessment after 119 studies]. Hach A; Wittig B; Piepenburg R; Steinert H; Lahmann C; Dippold W; Hahn K Rofo; 1992 Jul; 157(1):3-10. PubMed ID: 1638001 [TBL] [Abstract][Full Text] [Related]
10. Imaging of inflammation with granulocytes labelled in vivo. Joseph K; Höffken H; Bosslet K; Schorlemmer HU Nucl Med Commun; 1988 Oct; 9(10):763-9. PubMed ID: 3211435 [TBL] [Abstract][Full Text] [Related]
11. [Anaphylactic shock after repeated injection of 99mTc-labeled CEA antibody]. Rettenbacher L; Galvan G Nuklearmedizin; 1994 Jun; 33(3):127-8. PubMed ID: 8090628 [TBL] [Abstract][Full Text] [Related]
12. Lack of T-cell immunity in humans with preexisting anti-mouse immunoglobulin reactivity. Conry RM; Khazaeli MB; LoBuglio AF Cancer Res; 1992 Dec; 52(24):6979-82. PubMed ID: 1458491 [TBL] [Abstract][Full Text] [Related]
13. [Immunoscintigraphy for the detection of inflammation foci in bone and joint diseases]. Kroiss A; Böck F; Perneczky G; Auinger C; Weidlich G; Kleinpeter G; Brenner H Wien Klin Wochenschr; 1990 Dec; 102(24):713-7. PubMed ID: 2281674 [TBL] [Abstract][Full Text] [Related]
15. [Anti-CEA immunoscintigraphy in postoperative follow-up of tumor patients. Differentiated use of various monoclonal antibody preparations]. Leitha T; Baur M; Steger G; Dudczak R Wien Klin Wochenschr; 1990 Sep; 102(17):503-9. PubMed ID: 2264338 [TBL] [Abstract][Full Text] [Related]
16. The human antimouse immunoglobulin response and the anti-idiotypic network have no influence on clinical outcome in patients with minimal residual colorectal cancer treated with monoclonal antibody CO17-1A. Gruber R; van Haarlem LJ; Warnaar SO; Holz E; Riethmüller G Cancer Res; 2000 Apr; 60(7):1921-6. PubMed ID: 10766181 [TBL] [Abstract][Full Text] [Related]
17. A passive haemagglutination test for human anti-mouse antibody (HAMA) responses in patients undergoing immunoscintigraphy. Pimm MV; Leong KS; Markham AJ Nucl Med Commun; 1990 Feb; 11(2):121-6. PubMed ID: 2356066 [TBL] [Abstract][Full Text] [Related]
18. Decreased production of anti-mouse antibody after administration of human/mouse chimeric monoclonal antibody-neocarzinostatin conjugate to human. Yata Y; Otsuji E; Okamoto K; Tsuruta H; Kobayashi S; Toma A; Yamagishi H Hepatogastroenterology; 2003; 50(49):80-4. PubMed ID: 12629996 [TBL] [Abstract][Full Text] [Related]
19. Experience with the iodine-123 and technetium-99m labelled anti-granulocyte antibody MAb47: a comparison of labelling methods. Bläuenstein P; Locher JT; Seybold K; Koprivova H; Janoki GA; Mäcke HR; Hasler P; Ammann A; Novak-Hofer I; Smith A Eur J Nucl Med; 1995 Jul; 22(7):690-8. PubMed ID: 7498233 [TBL] [Abstract][Full Text] [Related]
20. Quantitation of human anti-mouse antibody in serum by flow cytometry. Labus JM; Petersen BH Cytometry; 1992; 13(3):275-81. PubMed ID: 1576893 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]